<DOC>
	<DOC>NCT02486536</DOC>
	<brief_summary>The aim of this study is to evaluate the ideal dose of PEG and timing of bowel preparation in patients referred for CE examination.</brief_summary>
	<brief_title>The Best Dosage and Timing of Polyethylene Glycol for Bowel Preparation Before Capsule Endoscopy</brief_title>
	<detailed_description />
	<criteria>Patients aged between 18 and 75 years and referred to capsule endoscopy because of suspected smallbowel disease are prospectively eligible for entry into the study. Age &lt; 18 or &gt; 75 years Known or suspected GI stricture or fistula A history of GI tract resection Swallowing disorders Intensive therapy with fasting and parenteral nutrition;with a disease that may reduce movement of the GI tract, such as diabetes mellitus Medications that could affect gastrointestinal movement within one week Implanted with a medical electronic device Active inflammatory bowel disease, toxic megacolon, toxic colitis Severe pulmonary, cardiac, renal, or hepatic disease Uncontrolled hypertension (systolic blood pressure&gt;170 mm Hg, diastolic blood pressure&gt;100 mm Hg); Disturbance of electrolytes Pregnancy or lactation Patients inability to provide written voluntary informed consent Participation in another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>capsule endoscopy</keyword>
	<keyword>polyethylene glycol</keyword>
	<keyword>bowel preparation solutions</keyword>
</DOC>